SIA
GSK icon

SkyView Investment Advisors’s GSK GSK Stock Holding History

SkyView Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,157
Closed -$302K – 312
2025
Q4 		$302K Buy
+6,157
New +$287K 0.04% 259
2025
Q3 		– Sell
-7,849
Closed -$303K – 333
2025
Q2 		$303K Buy
+7,849
New +$300K 0.04% 234
2023
Q2 		– Sell
-11,460
Closed -$408K – 798
2023
Q1 		$408K Buy
11,460
+2,136
+23% +$74.7K 0.1% 249
2022
Q4 		$328K Sell
9,324
-920
-9% -$30.6K 0.1% 262
2022
Q3 		$301K Buy
10,244
+2,890
+39% +$110K 0.09% 308
2022
Q2 		$400K Buy
+7,354
New +$406K 0.11% 270

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SkyView Investment Advisors's GSK Position: Q1 2026 in Review

SkyView Investment Advisors sold out of GSK (GSK) in Q1 2026, closing a stake of 6,157 shares — an estimated $302K sold.

SkyView Investment Advisors first reported a position in GSK in Q2 2022 and held it in 6 quarters. The position peaked at $408K in Q1 2023. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • SkyView Investment Advisors reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • SkyView Investment Advisors sold 6,157 GSK shares in Q1 2026, an estimated $302K.
  • SkyView Investment Advisors first reported a position in GSK in Q2 2022 and held it in 6 quarters.
  • SkyView Investment Advisors's GSK position peaked at $408K in Q1 2023.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on SkyView Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.